Cargando…
Nebulized hypertonic saline triggers nervous system-mediated active liquid secretion in cystic fibrosis swine trachea
Inhaled hypertonic saline (HTS) treatment is used to improve lung health in patients with cystic fibrosis (CF). The current consensus is that the treatment generates an osmotic gradient that draws water into the airways and increases airway surface liquid (ASL) volume. However, there is evidence tha...
Autores principales: | Luan, Xiaojie, Tam, Julian S., Belev, George, Jagadeeshan, Santosh, Murray, Brendan, Hassan, Noman, Machen, Terry E., Chapman, L. Dean, Ianowski, Juan P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345831/ https://www.ncbi.nlm.nih.gov/pubmed/30679487 http://dx.doi.org/10.1038/s41598-018-36695-4 |
Ejemplares similares
-
Cystic fibrosis swine fail to secrete airway surface liquid in response to inhalation of pathogens
por: Luan, Xiaojie, et al.
Publicado: (2017) -
Nebulized hypertonic saline in noncystic fibrosis bronchiectasis: a
comprehensive review
por: Máiz Carro, Luis, et al.
Publicado: (2019) -
Hypertonic Saline in Treatment of Pulmonary Disease in Cystic Fibrosis
por: Reeves, Emer P., et al.
Publicado: (2012) -
Add-on treatment with nebulized hypertonic saline in a child with plastic
bronchitis after the Glenn procedure,
por: Lis, Grzegorz, et al.
Publicado: (2014) -
Epinephrine Improves the Efficacy of Nebulized Hypertonic Saline in Moderate Bronchiolitis: A Randomised Clinical Trial
por: Flores-González, J. Carlos, et al.
Publicado: (2015)